5th International Conference on Heart and Cardiovascular Diseases

Cardiovascular surgery continues to evolve in parallel with the rapid expansion of transcatheter therapies redefining its role toward the most complex anatomical cases while simultaneously advancing minimally invasive and robotic surgical techniques. The Cardiovascular Surgery & Perioperative Cardiac Care session examines contemporary CABG vs. PCI outcomes in multivessel and left main coronary disease (EXCEL and NOBLE trial updates), minimally invasive mitral and tricuspid valve surgery, thoracic aortic surgery including endovascular aortic repair (TEVAR/EVAR), perioperative cardiac risk assessment using biomarker-guided and imaging-based protocols, enhanced recovery after cardiac surgery (ERAS) pathways, and the evolving role of mechanical circulatory support as a bridge to surgery.

Key Discussion Areas:

CABG vs. PCI in multivessel and left main disease: updated long-term outcomes

Minimally invasive and robotic cardiac surgery: current evidence and expansion

Thoracic aortic surgery: open repair, TEVAR, and hybrid approaches

Perioperative cardiac risk assessment: biomarker and imaging protocols

Enhanced recovery after cardiac surgery (ERAS): evidence and implementation

Mechanical circulatory support as bridge to surgery or decision

Cardiac surgery in high-risk and elderly patients: decision frameworks

Postoperative atrial fibrillation: prevention, management, and anticoagulation

Why Attend This Session?

Cardiac surgeons, anaesthesiologists, intensivists, interventional cardiologists, and perioperative medicine specialists will benefit from updates on surgical technique innovations, evidence-based perioperative protocols, and the collaborative heart team decision-making process for complex cardiovascular cases.

Related Topics:

• Interventional Cardiology & Structural Heart Disease
• Valvular Heart Disease
• Heart Failure & Cardiomyopathies
• Aortic Disease & Vascular Cardiology
• Cardiac Imaging & Advanced Diagnostics

Frequently Asked Questions:

1.How do CABG and PCI compare for left main coronary disease in 2026?

Long-term follow-up from EXCEL and NOBLE trials demonstrates that while PCI is acceptable for lower-complexity left main disease, CABG retains a survival advantage at 5–10 years in higher SYNTAX score patients and those with multivessel disease underscoring the importance of heart team-based anatomical and clinical risk assessment.

2.What is an ERAS pathway for cardiac surgery and what are its benefits?

Enhanced Recovery After Surgery (ERAS) protocols for cardiac surgery bundle evidence-based perioperative interventions including pre-operative optimisation, minimised opioid use, early extubation, and structured rehabilitation resulting in reduced ICU and hospital stay, lower complication rates, and improved patient-reported outcomes.